Description
Genovis is launching FabULOUS at the Well Characterized Biologicals conference in Washington DC on October 21. The product, which complements FabRICATOR, has already been tested by key customers in Europe and the US with positive results and is now being launched in a first phase through in-house sales and later through the company's global distributor network.“This new product is a completely new enzyme that offers our customers several alternative strategies for characterization of antibody molecules. Fabulous is a great addition to FabRICATOR and by using the two products together, the customer gets a fast method to characterize the hinge region of an antibody in detail, which is important in many antibody drug conjugate (ADC) drug candidates. Our R & D activities focus on products that can save time, simplify work and improve the quality of analyses for our customers and FabULOUS is a great example of it,” says Sarah Fredriksson, CEO of Genovis.
Genovis has developed the product FabULOUS, which can quickly generate fragments from IgG molecules. FabULOUS is a recombinant enzyme that cleaves IgG specifically, thereby generating three intact fragments of an antibody. The yield is high, the reaction rate is fast and the enzyme does not generate any further fragmentation. Customers will primarily use the product for screening of new drug substances and quality control of new antibody-based drugs.
